Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
about
Warm versus cold blood, and any blood versus crystalloid, cardioplegia in adults undergoing coronary artery bypass grafting surgery with cardiopulmonary bypassCardiovascular Actions and Therapeutic Potential of Tetramethylpyrazine (Active Component Isolated from Rhizoma Chuanxiong): Roles and MechanismsCardioprotection: a review of current practice in global ischemia and future translational perspectiveExpanding the clinical indications for α(1)-antitrypsin therapyProtein quality control and metabolism: bidirectional control in the heartScutellarin's Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-IαCardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injuryThrombus aspiration in acute myocardial infarction: Rationale and indication.Novel therapeutic strategies for ischemic heart diseaseResveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism.Lipopolysaccharide pretreatment protects against ischemia/reperfusion injury via increase of HSP70 and inhibition of NF-κB.The role and modulation of autophagy in experimental models of myocardial ischemia-reperfusion injuryInhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heartMediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols.Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in vivo after ischemia/reperfusionProtease-activated receptors and myocardial infarctionEnhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in miceH9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation.Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury.High-Dose Polymerized Hemoglobin Fails to Alleviate Cardiac Ischemia/Reperfusion Injury due to Induction of Oxidative Damage in Coronary Artery.Remote Ischemic Preconditioning Fails to Benefit Pediatric Patients Undergoing Congenital Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humansThe Long-Term Consumption of Ginseng Extract Reduces the Susceptibility of Intermediate-Aged Hearts to Acute Ischemia Reperfusion InjuryAcetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signalingActivated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart.Protective Effects of Scutellarin on Human Cardiac Microvascular Endothelial Cells against Hypoxia-Reoxygenation Injury and Its Possible Target-Related ProteinsA Role for Photobiomodulation in the Prevention of Myocardial Ischemic Reperfusion Injury: A Systematic Review and Potential Molecular Mechanisms.Myocardial ischemia reperfusion injury: from basic science to clinical bedside.Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling.Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.Protective Effects of L-Malate against Myocardial Ischemia/Reperfusion Injury in RatsAssociation of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction.The cardioprotective effects of citric Acid and L-malic Acid on myocardial ischemia/reperfusion injuryInhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice.Sivelestat attenuates myocardial reperfusion injury during brief low flow postischemic infusion.Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats.Preoperative graft assessment in aortocoronary bypass surgery.
P2860
Q24201526-B62486F9-D708-4839-B81E-4A11DE03F4E8Q26744567-8C96C243-506A-45FC-98C4-B68E76CFFAC6Q26996274-E51EE7B1-32DA-48F0-A9E0-6D685F36B5F2Q27000764-57B247AC-3862-42CB-B469-868FAB8A78C3Q28256472-38DFA335-D607-4561-A45C-8601046D4C3EQ28550064-0318483C-CC30-42B1-9295-E5C20A5C6CC1Q33606564-B78C2BE7-1472-43C7-9C36-1317BD570BD5Q33646549-9F54F4CC-06CE-443D-911F-68D79928D504Q33714350-16611A33-BA2E-4A22-B430-5512E3C62878Q34054638-0A8398F4-7BB1-43A8-B39C-A06C814266C9Q34251882-FD9A87FB-7CC5-4C87-AAB3-88E777DDAC2FQ34276258-820712F9-B35C-4F52-B1AB-F258018E37A0Q34531697-0287CC89-D7D8-4E2C-9205-9F8A607BF43EQ34797253-D153BCC8-8FE8-4F66-9FF9-7270056F1DD2Q34954474-E089578B-B89D-4FC7-AC71-066CA43BB9C1Q35019445-09D2FBBD-2319-4577-B49E-AE1D23C7A897Q35053534-CA71CEEB-B232-410F-B9EE-751311DFFA46Q35064243-00CB4431-980D-47D2-B2F7-3CD8F716317DQ35064542-F7F9686D-E92B-4630-A6A0-6AE1639AC38CQ35187068-C5D3D2BA-899E-441A-BB0F-C0FBC20DB396Q35299240-6F4E01E7-EA76-4C5A-A90D-B0D4BD6F2042Q35692991-249C872B-3A90-4DFD-9323-348B8AA083F8Q35804324-B635944B-44F1-444F-978E-1230596FFE51Q35825746-A7830595-8222-411D-9AEE-1C3515800AA8Q35848395-21B2DB2A-3047-4F25-A828-CD4A6BC3B01AQ35864427-00B848B7-78E6-443E-B5E6-83F4204C8482Q36184518-E6257482-21CF-46F8-B93A-3514B42BB667Q36207893-F49037A5-66F5-48C3-BED1-48ADC7DB5987Q36236278-7377EAF2-0C72-4AF2-AF20-96A087D2CA02Q36274955-D75E1724-D7BF-43DB-B677-2A05C7F98C03Q36278316-BB1AC92A-A211-48A5-B430-2E82C31FA84FQ36317323-1064AC4F-EF4F-4F20-A002-67D1920D10BAQ36509653-90508E72-08C0-4FA5-B948-AF78BE7B2EBDQ36578366-8833AF68-233F-49FC-A8F5-FC0F5C4DF222Q36603939-A6CDF85C-F6B3-473B-B7B4-5574E5B777DEQ36883254-E1B63A7B-2D56-4BB1-9DF9-B22DB312DC4FQ36907206-25E884F5-17FC-4DA9-8777-7B4293B24AA2Q36908051-778388B1-F7B3-4829-8AEA-D524442C20B5Q36988132-DB38420C-4AC5-43DE-B2FB-6C95F18C0F3CQ37106675-47799B76-EE76-4AD9-97B8-BAB2FEB149D3
P2860
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
@en
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
@nl
type
label
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
@en
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
@nl
prefLabel
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
@en
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
@nl
P2860
P1476
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
@en
P2093
Aslan T Turer
Joseph A Hill
P2860
P304
P356
10.1016/J.AMJCARD.2010.03.032
P407
P577
2010-08-01T00:00:00Z